Alcohol-Related Liver Experiments Linked Stellate-Cell 2-AG to Hepatocyte CB1
A liver endocannabinoid finding did not involve every liver cell in the same way. A review describes evidence for 2-AG generated by hepatic stellate cells acting on CB1 receptors in neighboring hepatocytes during alcohol-related steatosis experiments.
Cell origin and receptor location were separated
Kunos summarizes animal and co-culture work in which ethanol increased 2-AG-related signaling in stellate cells. Hepatocyte CB1 deletion and co-culture comparisons supported involvement of the neighboring receiving cell.
The reviewed findings connected this interaction with lipogenic gene expression and fatty liver changes. Anandamide did not show the same reported increase as 2-AG.
A tissue average can hide communication
A whole-liver analyte level does not, by itself, identify which cell produced the signal or which cell responded. The cell-specific manipulations added information beyond a tissue-level association.
The proposed mechanism was paracrine communication: a locally generated signal acting on nearby cells. That is different from assuming that all cells both generate and respond to the same signal equally.
Endocannabinoid biology is not a cannabis trial
The experiments examined endogenous signaling in alcohol exposure models. They did not administer a marijuana product to establish a clinical liver outcome.
The review supports a cell-specific mechanistic account and further target research. It does not quantify liver risk from an individual’s cannabis use or establish a treatment based on a tissue measurement alone.
Related: Interpreting cannabis tolerance claims.
Research cited
Kunos G Alcoholism, clinical and experimental research · 2020 · 44(4):790 PMID 32056226 · DOI 10.1111/acer.14306. Interactions Between Alcohol and the Endocannabinoid System..
